SlideShare a Scribd company logo
PERTUSSIS
K.R POKHREL
MBBS,KUSMS
Pertussis
-whooping cough ,100 days cough
-pertussis=intense cough(most individuals don’t
whoop)
Causative agent:
-Bordetella Pertussis
-Bordetella Parapertussis
-Bordetella Holmessi,Bordetella Bronchiseptica
• Small,ovoid,fastidious,Gram negative
coccobacilli,0.5 microns length
• Nonmotile,non sporing,capsulated,aerobic
• Colonize only ciliated epithelium
Epidemiology
• Worldwide
• 1922-1948 leading cause of death
• 2008(WHO)-16 million cases;195000
childhood deaths esp in developing countries
• U.S-leading cause of death <14 yrs(10000
deaths/yr)before vaccines were available
• After the advent of pertussis vaccine->99%
decline on cases and shift of disease burden to
adolescents and adults
• Extremely contagious-attack rates 80-100%
• Source of infection=cases
• Chronic carriers not known
• Immunity never complete(waning protection following
vaccination)
• Adolescents and adults are major reservoir but
unrecognized
• Age:any age, most prevalent(<5 yrs )most severe(<6
months)
• Incubation Period:3-12 days
• Infectivity:first 4 weeks
• Transmission by droplets and direct contact
• Nepal 2015 A.D
-4416 cases of pertussis reported
-DTP3 coverage of 91%
2016 A.D
-4890 cases of pertussis reported
-DTP3 coverage 87%
Pathogenesis(toxin mediated)
Aerosol acquisition
colonize ciliated epithelium of respiratory tract(via
adhesins)
Expression of toxins (Pertussis toxin,Tracheal
cytotoxin,Adenylate cyclase,Dermonecrotic factor)
Paralyze cilia,Increase in cAMP(mucus
hypersecretion,inflammation) and inhibit clearance
of organisms-interferes with clearing of secretions
modifies host defences(lymphocytosis+impaired
chemotaxis)
local epithelial damage causing respiratory
symptoms and invasion into tissues(macrophages)
Immune response by body
Neutralization the toxins
Clinical Manifestations
• 3 Stages
1)Catarrhal Stage
• 1-2 weeks
• Congestion,rhinorrhea,
• low grade fever
• sneezing,lacrimation,conjunctival suffusion
• Most contagious at this stage
2)Paroxysmal Stage
• 2-6 weeks
• Coughing marks its onset
• Initially dry,irritant,intermittent hack
• Progresses to inexorable paroxysm(hallmarks
of pertussis)
• Machine gun burst of uninterrupted cough on
a single exhalation
• Chin and chest held forward
• Tongue maximally protruded
• Eyes bulging ,watering
• Face red then blue
• Loud whoop(high pitched inspiration) at the end
of paroxysm
• Posttussive emesis and exhaustion
• Number and severity progresses over days to
weeks then plateau for days to week(peak >1
episodes/hr)
• 3)Convalescent Stage(>/=2 weeks)
• Number,severity and duration of episodes
diminishes
• Upto months
• Risk of developing secondary infections
common in this stage
Infants <3 months
• No classical stages
• Well appearing infant suddenly
chokes,gasps,gags,flail extremities,reddened
face
• Cough not prominent,whoop infrequent
• Apnea and cyanosis
• Young infants-paroxysmal and convalescent
stage longer
• Immunized children-foreshortened stages
• Adolescents and adults-no distinct stage,milder
-sudden feeling of strangulation
-suffocation,headache,diminished
awareness
-gasping without whoop
-post tussive emesis and intermittent
paroxysms separated by hours of well being
-non specific cough>21 days
• Physical examination not informative
-signs of LRT involvement,conjunctival
hemorrhages and petechiae
Diagnosis
• Clinical Diagnosis-Paroxysmal stage
• Suspect if predominant cough with absent
-fever,malaise,myalgia,rash,sorethroat,
hoarseness,tachypnea,wheeze,crepitations
• Cough>/=14 days+symptoms of paroxysm,whoop
or post tussive emesis
• Older children=escalating intermittent cough for
7-10 days
• <3 months=gagging,gasping,apnea,cyanosis
Investigations
1.Blood Count
-leukocytosis(15000-100000/mm3)with absolute
lymphocytosis(>/=50%)
2.Culture
-Nasopharyngeal aspirate(dacron/calcium alginate swabs)
-Bordet Gengou Potato Infusion media,Regan Lowe
charcoal media
3.Fluorescent Antibody staining,Serology
4.PCR
5.Chest Xray
-perihilar infiltrates,atelectasis
• Gram negative coccobacilli
• B.G media-small,white domed pearls
• R.L media-mercury droplets
Differential Diagnosis
• Viral infections(Adenovirus,Respiratory
Syncytial Virus)-
fever,sorethroat,conjunctivitis,LRT signs
• Chlamydial Infections-
conjunctivitis,tachypnea,rales
• Mycoplasma infection-
fever,headache,rales,continous cough
• Pulmonary tuberculosis-fever,weight
loss,night sweats
Complications
1.Respiratory
-Apnea,Respiratory failure
-Bronchopneumonia
-Atelectasis
-Bronchiectasis
-Pneumothorax,Emphysema
-Pulmonary Hypertension
-Reactivation of quiescient TB
Others -Otitis media
2.Sequelae of forceful cough
-Epistaxis,Sub conjunctival and scleral
hemorrhage
-petechia on upper body
-Intracranial bleeding
-Retinal hemorrhage
-Umbilical and inguinal hernia
-Rectal prolpase
-Dehydration,malnutrition
3.CNS
-convulsions,encephalopathy
Treatment
Specific(antibiotics)
• Effective in early catarrhal phase
• Late phases-reduce transmission but doesn’t alter the
course of disease(>3 wks and not pregnant=no role)
• Primary agents
-Azithromycin-DOC(10mg/kg/day once daily for 5 days)
-Erythromycin(40-50 mg/kg/day in 4 divided doses for 14
days)
-substantial risk for infantile hypertrophic pyloric stenosis
with erythromycin
• Secondary agents
-Clarithromycin 15mg/kg/day in 2 divided doses for
7 days
-Cotrimoxazole(TMP 8mg/kg/day + SMZ 40mg/kg
day)in 2divided doses for 14 days
• CI in <2 months
No role for adjunct therapies(B2 agonists,
corticosteriods)
General Measures
• Young infants should be hospitalised
• Adequate hydration and nutrition
• Oxygen,Mechanical ventilation
• Quiet environment
Paroxysms-not life threatening
-<45 secs,red but not blue color change
-tachycardia,bradycardia or oxygen desaturation with
spontaneous resolution after paroxysm
-whooping,self expectoration of mucus plug
-post tussive exhaustion but not unresponsiveness
Criteria for Discharge
• Disease severity unchanged/diminished over
48 hr period
• No intervention required during paroxysm
• Adequate nutrition
• No complications
• Parents prepared for care at home
Care of household and close contacts
• Macrolides given(irrespective of
age,immunization status,symptoms)-dose same
as for treatment
• Vaccination
-close contacts <7 yrs , < 4 doses then complete the
series
-< 7 yrs,3rd dose >6months before exposure
-<7 yrs,4th dose>/=3 yrs before exposure
->9 yrs give if not previously received
• If contacts develop cough-evaluate for pertussis
booster
Prevention
• Vaccination
-2 types:DPT(whole cell) and DTaP(acellular)
-DPT vaccine in Nepal(Since 2009 A.D,component of
pentavalent)
-0.5ml IM in anterolateral thigh at 6,10 and 14
weeks included in National EPI schedule of Nepal
-recommendation:5 doses:4 in 1st 2yrs of life,6
months gap between 3rd and 4th
5th dose-4-6 yrs;not required if 4th dose acquired at
or after 4th birthday
-only acellular vaccines for older children and adults
• Adverse effects-fever,pain,redness,swelling
• Rarely abscess formation,inconsolable
screaming,seizures,hypotonic
hyporesponsiveness,anaphylaxis
• Contraindications
-Progressive neurological disease
-anaphylaxis after previous dose
-encephalopathy within 7 days of previous dose
• Tdap-in pregnant??
-passive immunity to child until vaccinated
• Continues to be endemic despite high vaccination coverage
References
• Nelson Textbook of Pediatrics 20th Edition
• Park’s Textbook of Preventive and Social Medicine
22nd Edition
• http://www.searo.who.int/immunization/data/ne
pal
• UPTODATE
Thank You!!!

More Related Content

What's hot

Rickettsial ds
Rickettsial dsRickettsial ds
Rickettsial ds
PGIMER,DR.RML HOSPITAL
 
Scarlet fever case study
Scarlet fever case studyScarlet fever case study
Scarlet fever case study
Arsenic Halcyon
 
Measles
MeaslesMeasles
Measles
MeaslesMeasles
Diphtheria ppt
Diphtheria pptDiphtheria ppt
Diphtheria ppt
hemana hemu
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
KULDEEP VYAS
 
Measles
MeaslesMeasles
Measles
Sushan Gaire
 
8 measles
8 measles8 measles
8 measles
Sumit Prajapati
 
Mumps
MumpsMumps
Measles
MeaslesMeasles
Pertussis dr yusuf imran
Pertussis  dr yusuf imranPertussis  dr yusuf imran
Diphtheria
DiphtheriaDiphtheria
Diphtheria
DrRajalekshmy Arun
 
Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)
Grant Medical College, Mumbai
 
Pertussis
PertussisPertussis
Pertussis
Sayan Misra
 
Pertussis
PertussisPertussis
Pertussis
Alisha Talwar
 
Bordetella pertussis depa
Bordetella pertussis depaBordetella pertussis depa
Bordetella pertussis depa
SR MEDICAL COLLEGE VARKALA TRIVANDRUM
 
Tetanus in children Dr. ozil
Tetanus in children  Dr. ozilTetanus in children  Dr. ozil
Tetanus in children Dr. ozil
Dr. Ozil Abdullahi
 
Human para influenza virus
Human para influenza virusHuman para influenza virus
Human para influenza virus
Arsenic Halcyon
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
Subha Sri Aala
 
Lecture enteroviruses
Lecture enterovirusesLecture enteroviruses
Lecture enteroviruses
deepak deshkar
 

What's hot (20)

Rickettsial ds
Rickettsial dsRickettsial ds
Rickettsial ds
 
Scarlet fever case study
Scarlet fever case studyScarlet fever case study
Scarlet fever case study
 
Measles
MeaslesMeasles
Measles
 
Measles
MeaslesMeasles
Measles
 
Diphtheria ppt
Diphtheria pptDiphtheria ppt
Diphtheria ppt
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
 
Measles
MeaslesMeasles
Measles
 
8 measles
8 measles8 measles
8 measles
 
Mumps
MumpsMumps
Mumps
 
Measles
MeaslesMeasles
Measles
 
Pertussis dr yusuf imran
Pertussis  dr yusuf imranPertussis  dr yusuf imran
Pertussis dr yusuf imran
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
 
Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)
 
Pertussis
PertussisPertussis
Pertussis
 
Pertussis
PertussisPertussis
Pertussis
 
Bordetella pertussis depa
Bordetella pertussis depaBordetella pertussis depa
Bordetella pertussis depa
 
Tetanus in children Dr. ozil
Tetanus in children  Dr. ozilTetanus in children  Dr. ozil
Tetanus in children Dr. ozil
 
Human para influenza virus
Human para influenza virusHuman para influenza virus
Human para influenza virus
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
 
Lecture enteroviruses
Lecture enterovirusesLecture enteroviruses
Lecture enteroviruses
 

Similar to Pertussis

ARI Year 2019.pptx
ARI Year 2019.pptxARI Year 2019.pptx
ARI Year 2019.pptx
Dr. Rashmi B.M.
 
Acute respiratory infections
Acute respiratory infections Acute respiratory infections
Acute respiratory infections
MD Danish Rizvi
 
Diphtheria and pertussis (whooping cough)
Diphtheria and pertussis (whooping cough)Diphtheria and pertussis (whooping cough)
Diphtheria and pertussis (whooping cough)
Rizwan S A
 
Acute Respiratory infecions
Acute Respiratory infecionsAcute Respiratory infecions
Acute Respiratory infecions
Deepak Upadhyay
 
Acute respiratory infections
Acute respiratory infectionsAcute respiratory infections
Acute respiratory infections
Mallik Arjun D
 
acuterespiratoryinfections-161205075803.pdf
acuterespiratoryinfections-161205075803.pdfacuterespiratoryinfections-161205075803.pdf
acuterespiratoryinfections-161205075803.pdf
AkshayBadore2
 
20180319 poliomyelitis
20180319 poliomyelitis20180319 poliomyelitis
20180319 poliomyelitis
Sushrit Neelopant
 
Whooping cough
Whooping coughWhooping cough
Whooping cough
DrRajalekshmy Arun
 
Pertusis
PertusisPertusis
20180211 pertussis
20180211 pertussis20180211 pertussis
20180211 pertussis
Sushrit Neelopant
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
KaustubhMohite4
 
Pertussis
PertussisPertussis
Pertussis
PertussisPertussis
Seminar-1.pptx
Seminar-1.pptxSeminar-1.pptx
Seminar-1.pptx
shewly shimu das
 
Seminar-1.pptx
Seminar-1.pptxSeminar-1.pptx
Seminar-1.pptx
shewly shimu das
 
Pertusses associated cough
Pertusses associated coughPertusses associated cough
Pertusses associated cough
AhmadAbunaglah
 
Measles infection and mmr
Measles  infection  and mmrMeasles  infection  and mmr
Measles infection and mmr
Magdy Shafik M. Ramadan
 
Rubella.pptx
Rubella.pptxRubella.pptx
Rubella.pptx
JazeelaMohamedSiddiq
 
Case presentation tb meningitis
Case presentation tb meningitisCase presentation tb meningitis
Case presentation tb meningitis
Prajjwal Malla
 
Bronchiolitis overview
Bronchiolitis   overviewBronchiolitis   overview
Bronchiolitis overview
Sid Kaithakkoden
 

Similar to Pertussis (20)

ARI Year 2019.pptx
ARI Year 2019.pptxARI Year 2019.pptx
ARI Year 2019.pptx
 
Acute respiratory infections
Acute respiratory infections Acute respiratory infections
Acute respiratory infections
 
Diphtheria and pertussis (whooping cough)
Diphtheria and pertussis (whooping cough)Diphtheria and pertussis (whooping cough)
Diphtheria and pertussis (whooping cough)
 
Acute Respiratory infecions
Acute Respiratory infecionsAcute Respiratory infecions
Acute Respiratory infecions
 
Acute respiratory infections
Acute respiratory infectionsAcute respiratory infections
Acute respiratory infections
 
acuterespiratoryinfections-161205075803.pdf
acuterespiratoryinfections-161205075803.pdfacuterespiratoryinfections-161205075803.pdf
acuterespiratoryinfections-161205075803.pdf
 
20180319 poliomyelitis
20180319 poliomyelitis20180319 poliomyelitis
20180319 poliomyelitis
 
Whooping cough
Whooping coughWhooping cough
Whooping cough
 
Pertusis
PertusisPertusis
Pertusis
 
20180211 pertussis
20180211 pertussis20180211 pertussis
20180211 pertussis
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
 
Pertussis
PertussisPertussis
Pertussis
 
Pertussis
PertussisPertussis
Pertussis
 
Seminar-1.pptx
Seminar-1.pptxSeminar-1.pptx
Seminar-1.pptx
 
Seminar-1.pptx
Seminar-1.pptxSeminar-1.pptx
Seminar-1.pptx
 
Pertusses associated cough
Pertusses associated coughPertusses associated cough
Pertusses associated cough
 
Measles infection and mmr
Measles  infection  and mmrMeasles  infection  and mmr
Measles infection and mmr
 
Rubella.pptx
Rubella.pptxRubella.pptx
Rubella.pptx
 
Case presentation tb meningitis
Case presentation tb meningitisCase presentation tb meningitis
Case presentation tb meningitis
 
Bronchiolitis overview
Bronchiolitis   overviewBronchiolitis   overview
Bronchiolitis overview
 

Recently uploaded

RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Himanshu Rai
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17
Celine George
 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
imrankhan141184
 
Standardized tool for Intelligence test.
Standardized tool for Intelligence test.Standardized tool for Intelligence test.
Standardized tool for Intelligence test.
deepaannamalai16
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
khuleseema60
 
Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"
National Information Standards Organization (NISO)
 
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
Nguyen Thanh Tu Collection
 
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
EduSkills OECD
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
Steve Thomason
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
سمير بسيوني
 
Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)
nitinpv4ai
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
danielkiash986
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
deepaannamalai16
 
How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17
Celine George
 
Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
MysoreMuleSoftMeetup
 
Skimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S EliotSkimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S Eliot
nitinpv4ai
 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
TechSoup
 
Temple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation resultsTemple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation results
Krassimira Luka
 

Recently uploaded (20)

RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17
 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
 
Standardized tool for Intelligence test.
Standardized tool for Intelligence test.Standardized tool for Intelligence test.
Standardized tool for Intelligence test.
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
 
Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"
 
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
 
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
 
Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
 
How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17How Barcodes Can Be Leveraged Within Odoo 17
How Barcodes Can Be Leveraged Within Odoo 17
 
Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
 
Skimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S EliotSkimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S Eliot
 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
 
Temple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation resultsTemple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation results
 

Pertussis

  • 2. Pertussis -whooping cough ,100 days cough -pertussis=intense cough(most individuals don’t whoop) Causative agent: -Bordetella Pertussis -Bordetella Parapertussis -Bordetella Holmessi,Bordetella Bronchiseptica
  • 3. • Small,ovoid,fastidious,Gram negative coccobacilli,0.5 microns length • Nonmotile,non sporing,capsulated,aerobic • Colonize only ciliated epithelium
  • 4. Epidemiology • Worldwide • 1922-1948 leading cause of death • 2008(WHO)-16 million cases;195000 childhood deaths esp in developing countries • U.S-leading cause of death <14 yrs(10000 deaths/yr)before vaccines were available • After the advent of pertussis vaccine->99% decline on cases and shift of disease burden to adolescents and adults
  • 5. • Extremely contagious-attack rates 80-100% • Source of infection=cases • Chronic carriers not known • Immunity never complete(waning protection following vaccination) • Adolescents and adults are major reservoir but unrecognized • Age:any age, most prevalent(<5 yrs )most severe(<6 months) • Incubation Period:3-12 days • Infectivity:first 4 weeks • Transmission by droplets and direct contact
  • 6. • Nepal 2015 A.D -4416 cases of pertussis reported -DTP3 coverage of 91% 2016 A.D -4890 cases of pertussis reported -DTP3 coverage 87%
  • 7. Pathogenesis(toxin mediated) Aerosol acquisition colonize ciliated epithelium of respiratory tract(via adhesins) Expression of toxins (Pertussis toxin,Tracheal cytotoxin,Adenylate cyclase,Dermonecrotic factor) Paralyze cilia,Increase in cAMP(mucus hypersecretion,inflammation) and inhibit clearance of organisms-interferes with clearing of secretions
  • 8. modifies host defences(lymphocytosis+impaired chemotaxis) local epithelial damage causing respiratory symptoms and invasion into tissues(macrophages) Immune response by body Neutralization the toxins
  • 9. Clinical Manifestations • 3 Stages 1)Catarrhal Stage • 1-2 weeks • Congestion,rhinorrhea, • low grade fever • sneezing,lacrimation,conjunctival suffusion • Most contagious at this stage
  • 10. 2)Paroxysmal Stage • 2-6 weeks • Coughing marks its onset • Initially dry,irritant,intermittent hack • Progresses to inexorable paroxysm(hallmarks of pertussis) • Machine gun burst of uninterrupted cough on a single exhalation
  • 11. • Chin and chest held forward • Tongue maximally protruded • Eyes bulging ,watering • Face red then blue • Loud whoop(high pitched inspiration) at the end of paroxysm • Posttussive emesis and exhaustion • Number and severity progresses over days to weeks then plateau for days to week(peak >1 episodes/hr)
  • 12. • 3)Convalescent Stage(>/=2 weeks) • Number,severity and duration of episodes diminishes • Upto months • Risk of developing secondary infections common in this stage
  • 13. Infants <3 months • No classical stages • Well appearing infant suddenly chokes,gasps,gags,flail extremities,reddened face • Cough not prominent,whoop infrequent • Apnea and cyanosis • Young infants-paroxysmal and convalescent stage longer • Immunized children-foreshortened stages
  • 14. • Adolescents and adults-no distinct stage,milder -sudden feeling of strangulation -suffocation,headache,diminished awareness -gasping without whoop -post tussive emesis and intermittent paroxysms separated by hours of well being -non specific cough>21 days • Physical examination not informative -signs of LRT involvement,conjunctival hemorrhages and petechiae
  • 15. Diagnosis • Clinical Diagnosis-Paroxysmal stage • Suspect if predominant cough with absent -fever,malaise,myalgia,rash,sorethroat, hoarseness,tachypnea,wheeze,crepitations • Cough>/=14 days+symptoms of paroxysm,whoop or post tussive emesis • Older children=escalating intermittent cough for 7-10 days • <3 months=gagging,gasping,apnea,cyanosis
  • 16. Investigations 1.Blood Count -leukocytosis(15000-100000/mm3)with absolute lymphocytosis(>/=50%) 2.Culture -Nasopharyngeal aspirate(dacron/calcium alginate swabs) -Bordet Gengou Potato Infusion media,Regan Lowe charcoal media 3.Fluorescent Antibody staining,Serology 4.PCR 5.Chest Xray -perihilar infiltrates,atelectasis
  • 17. • Gram negative coccobacilli • B.G media-small,white domed pearls • R.L media-mercury droplets
  • 18. Differential Diagnosis • Viral infections(Adenovirus,Respiratory Syncytial Virus)- fever,sorethroat,conjunctivitis,LRT signs • Chlamydial Infections- conjunctivitis,tachypnea,rales • Mycoplasma infection- fever,headache,rales,continous cough • Pulmonary tuberculosis-fever,weight loss,night sweats
  • 20. 2.Sequelae of forceful cough -Epistaxis,Sub conjunctival and scleral hemorrhage -petechia on upper body -Intracranial bleeding -Retinal hemorrhage -Umbilical and inguinal hernia -Rectal prolpase -Dehydration,malnutrition 3.CNS -convulsions,encephalopathy
  • 21. Treatment Specific(antibiotics) • Effective in early catarrhal phase • Late phases-reduce transmission but doesn’t alter the course of disease(>3 wks and not pregnant=no role) • Primary agents -Azithromycin-DOC(10mg/kg/day once daily for 5 days) -Erythromycin(40-50 mg/kg/day in 4 divided doses for 14 days) -substantial risk for infantile hypertrophic pyloric stenosis with erythromycin
  • 22. • Secondary agents -Clarithromycin 15mg/kg/day in 2 divided doses for 7 days -Cotrimoxazole(TMP 8mg/kg/day + SMZ 40mg/kg day)in 2divided doses for 14 days • CI in <2 months No role for adjunct therapies(B2 agonists, corticosteriods)
  • 23. General Measures • Young infants should be hospitalised • Adequate hydration and nutrition • Oxygen,Mechanical ventilation • Quiet environment Paroxysms-not life threatening -<45 secs,red but not blue color change -tachycardia,bradycardia or oxygen desaturation with spontaneous resolution after paroxysm -whooping,self expectoration of mucus plug -post tussive exhaustion but not unresponsiveness
  • 24. Criteria for Discharge • Disease severity unchanged/diminished over 48 hr period • No intervention required during paroxysm • Adequate nutrition • No complications • Parents prepared for care at home
  • 25. Care of household and close contacts • Macrolides given(irrespective of age,immunization status,symptoms)-dose same as for treatment • Vaccination -close contacts <7 yrs , < 4 doses then complete the series -< 7 yrs,3rd dose >6months before exposure -<7 yrs,4th dose>/=3 yrs before exposure ->9 yrs give if not previously received • If contacts develop cough-evaluate for pertussis booster
  • 26. Prevention • Vaccination -2 types:DPT(whole cell) and DTaP(acellular) -DPT vaccine in Nepal(Since 2009 A.D,component of pentavalent) -0.5ml IM in anterolateral thigh at 6,10 and 14 weeks included in National EPI schedule of Nepal -recommendation:5 doses:4 in 1st 2yrs of life,6 months gap between 3rd and 4th 5th dose-4-6 yrs;not required if 4th dose acquired at or after 4th birthday -only acellular vaccines for older children and adults
  • 27. • Adverse effects-fever,pain,redness,swelling • Rarely abscess formation,inconsolable screaming,seizures,hypotonic hyporesponsiveness,anaphylaxis • Contraindications -Progressive neurological disease -anaphylaxis after previous dose -encephalopathy within 7 days of previous dose • Tdap-in pregnant?? -passive immunity to child until vaccinated • Continues to be endemic despite high vaccination coverage
  • 28. References • Nelson Textbook of Pediatrics 20th Edition • Park’s Textbook of Preventive and Social Medicine 22nd Edition • http://www.searo.who.int/immunization/data/ne pal • UPTODATE Thank You!!!

Editor's Notes

  1. B pertussis-epidemics and sporadic cases B parapertussis-<5%
  2. Adhesins and Toxins
  3. Protection wanes of in 6-12 yrs following vaccination
  4. Culture 30-50% positive,may take upto 2 weeks’;less likely to be positive if >2 weeks after cough onset or from vaccinated/treated individuals PCR-high sensitivity.many false positives,variable specificity;upto 3 weeks of cough onset accurate results;>4 weeks DNA levels fall so PCR unreliable Serology-effective in later stage when cultures and PCR likely to be negative;highest yield 2-8 weeks following cough onset
  5. Charcoal containing media bordet gengou Slow growing 48-72 hrs
  6. Risk for kernicterus with SMZ so CI in <2 months
  7. DPT-whole cell vaccine,used in developing countries,effective for long duration =10 yrs DTaP-acellular,developed countries,less side effects,effective for shorter duration,less reactogenicity,more expensive Efficacy=85% Protection for 6-12 years following 3 doses and 1 booster which is similar/shorter to that following natural infection
  8. Tdap-tetanus,reduced diphtheria and acellular pertussis,used in developed countries,pregnant women optimal time 26-37 weeks,confers passive immunity to child until he/she receives vaccines